INTERIM ANALYSIS OF MAGNIFY PHASE IIIB: INDUCTION R2 FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY (R/R) INDOLENT NON-HODGKIN LYMPHOMA (INHL)

MLA

Morton Coleman, et al. “Interim Analysis of Magnify Phase Iiib: Induction R2 Followed by Maintenance in Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (Inhl).” Hematology, Transfusion and Cell Therapy, vol. 42, Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6ca189b1d9fa4e28ad597c136e5b48c7&authtype=sso&custid=ns315887.

APA

Morton Coleman, Kathryn S. Kolibaba, Jason M. Melear, C. Reynolds, Abdulraheem Yacoub, A.L. Et, G.S. Nowakowski, Frederick Lansigan, Suzanne R. Fanning, & D.J. Andorsky. (2020). Interim Analysis of Magnify Phase Iiib: Induction R2 Followed by Maintenance in Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (Inhl). Hematology, Transfusion and Cell Therapy, 42.

Chicago

Morton Coleman, Kathryn S. Kolibaba, Jason M. Melear, C. Reynolds, Abdulraheem Yacoub, A.L. Et, G.S. Nowakowski, Frederick Lansigan, Suzanne R. Fanning, and D.J. Andorsky. 2020. “Interim Analysis of Magnify Phase Iiib: Induction R2 Followed by Maintenance in Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (Inhl).” Hematology, Transfusion and Cell Therapy 42 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6ca189b1d9fa4e28ad597c136e5b48c7&authtype=sso&custid=ns315887.